Table 1 Summary of Patients Treated
From: Feasibility investigation of allogeneic endometrial regenerative cells
Patient | Condition | Route | Total Injected | Follow Up | Notable Events |
|---|---|---|---|---|---|
AA | MS | IV & IT | 16 million | 12 months | None |
PW | MS | IT | 30 million | 2 months | None |
RH | MS | IT | 30 million | 2 months | None |
JU | MS | IT | 30 million | 5 months | None |